CalciMedica, Inc. Operating Income Loss

• CalciMedica, Inc. showed an increase of +4.5% in Operating Income Loss from 2024 to 2025.
• This data is from CalciMedica, Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
• XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 7 years of available data (2019 to 2025), CalciMedica, Inc.'s Operating Income Loss has grown by 38.3%.
• Historical annual values: Fiscal year 2025: -$23.12 million | Fiscal year 2024: -$24.20 million | Fiscal year 2023: -$38.08 million | Fiscal year 2022: -$14.19 million | Fiscal year 2021: -$35.95 million | Fiscal year 2020: -$29.83 million | Fiscal year 2019: -$37.50 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026